A study by researchers at the UNC Eshelman School of Pharmacy and Lineberger Comprehensive Cancer Center determined the cost savings for a generic version of an orally administered cancer treatment were less than expected — a finding that questions the … Read more
Jennifer Lafata, Ph.D., professor in the Division of Pharmaceutical Outcomes and Policy at the UNC Eshelman School of Pharmacy will take over as its vice chair upon the retirement of Susan Blalock, Ph.D., M.P.H, professor in DPOP and current vice … Read more
Physicians paid by pharmaceutical companies for meals, talks and travel had higher odds of prescribing those companies’ drugs to treat two cancer types, a University of North Carolina at Chapel Hill study has found. “Ideally, therapy choices should be based … Read more
Children with attention deficit hyperactivity disorder want to ask their physicians about their condition and medications but often don’t, according to researchers at the University of North Carolina at Chapel Hill. “We have found that there has been very little … Read more
Stacie Dusetzina, Ph.D., has been confirmed as a committee member for the National Academies of Sciences, Engineering and Medicine report titled “Ensuring Patient Access to Affordable Drug Therapies.” The committee is charged by the National Academy of Medicine (formerly the … Read more
Giving patients hard numbers about the likelihood of experiencing side effects from a new medication makes them more likely to take the drug, according to a new study fromthe UNC Eshelman School of Pharmacy. Conversely, giving them similar information about … Read more
The significant out-of-pocket costs that cancer patients can face before Medicare drug benefits kick in may delay the patients’ treatment with a new class of highly effective therapies, according to a University of North Carolina study. In the study published … Read more
Professor Sue Blalock, Ph.D., M.P.H., has been appointed chairperson of the Food and Drug Administration’s Risk Communication Advisory Committee, effective until Sept. 30, 2018. She has been a member of the committee since 2013. Blalock is a professor in the … Read more
Jennifer Elston Lafata, Ph.D., has joined the UNC Eshelman School of Pharmacy as a full professor with tenure in the Division of Pharmaceutical Outcomes and Policy. She will serve as associate director of the UNC Institute for Healthcare Quality Improvement … Read more
Nearly 9 out of 10 physicians and researchers who helped develop a leading set of cancer-care guidelines in the United States reported financial ties to the pharmaceutical and medical device industries, a University of North Carolina at Chapel Hill study … Read more
